Kiniksa Pharmaceuticals International (KNSA) Asset Utilization Ratio (2022 - 2026)
Kiniksa Pharmaceuticals International's Asset Utilization Ratio came in at 0.98 for Q2 2026, up 16.3% from 0.84 a year earlier and up 2.9% from the prior quarter.
Powered by 
Analysis
Kiniksa Pharmaceuticals International (KNSA) Asset Utilization Ratio (2022 - 2026) Analysis & Trends
For FY2025, Kiniksa Pharmaceuticals International's Asset Utilization Ratio was 1.01, up 31.8% from FY2024.
- Going back by year, Asset Utilization Ratio was 0.76 in FY2024 (+39.5%), 0.55 in FY2023 (-13.8%), 0.64 in FY2022 (+380.3%) and 0.13 in FY2021.
- The Q2 2026 figure represents the highest quarterly Asset Utilization Ratio in data going back to Q1 2022.
- Year-over-year, Asset Utilization Ratio has increased for 11 consecutive quarters, with growth averaging 28.6% over the last eight quarters.
- The fastest year-over-year change in Asset Utilization Ratio over five years came in Q1 2023 (growth of 71.7%), and the weakest in Q3 2023 (a decline of 2.6%).
- Business Quant data shows KNSA's Asset Utilization Ratio at 0.95 (Q1 2026), 0.92 (Q4 2025) and 0.87 (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 0.62 |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 0.49 |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 0.47 |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 0.52 |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 0.46 |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 0.51 |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 0.40 |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 0.58 |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 0.31 |
| 10 | Kiniksa Pharmaceuticals International | 6.18 Bn | 4.92 Bn | 220.03 Mn | 0.98 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 0.98 |
| Mar 31, 2026 | 0.95 |
| Dec 31, 2025 | 0.92 |
| Sep 30, 2025 | 0.87 |
| Jun 30, 2025 | 0.84 |
| Mar 31, 2025 | 0.82 |
| Dec 31, 2024 | 0.75 |
| Sep 30, 2024 | 0.70 |
| Jun 30, 2024 | 0.64 |
| Mar 31, 2024 | 0.58 |
| Dec 31, 2023 | 0.54 |
| Sep 30, 2023 | 0.51 |
| Jun 30, 2023 | 0.61 |
| Mar 31, 2023 | 0.52 |
| Dec 31, 2022 | 0.48 |
| Sep 30, 2022 | 0.53 |
| Jun 30, 2022 | 0.41 |
| Mar 31, 2022 | 0.31 |
API Access
Kiniksa Pharmaceuticals International Asset Utilization Ratio API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=asset-utilization-ratio&ticker=KNSA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "asset-utilization-ratio", "ticker": "KNSA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=asset-utilization-ratio&ticker=KNSA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();